Updated Jul 16, 2026
Koppikar Utpal has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Utpal Koppikar is identified in SEC filings as a director of C4 Therapeutics, Inc. as of the dating of the most recent filing (2026-06-26). The available SEC context confirms his role on the company's board, but provides no additional background or prior positions.
| Role | Director |
|---|---|
| Notability | 40/100 |
Utpal Koppikar is identified in SEC filings as a director of C4 Therapeutics, Inc. as of the dating of the most recent filing (2026-06-26). The available SEC context confirms his role on the company's board, but provides no additional background or prior positions.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Koppikar Utpal profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.